I’ve always believed that running a business is like driving a high-performance race car. The executives are at the wheel, making split-second decisions at high speed. Marketing, sales, and operations are the wheels and suspension, keeping the vehicle moving and…

In the ever-evolving landscape of pharmaceuticals, one of the more nuanced and strategic decisions a brand company can make is whether to launch an Authorized Generic (AGx) product. I’ve been fortunate to work closely with clients navigating this decision, and…

Working in the pharmaceutical space, I’ve witnessed firsthand how biosimilars have shifted from a theoretical disruption to a real force reshaping market dynamics. Whether you’re on the innovator side trying to protect share or part of a biosimilar team plotting…

Competitive intelligence in biotech and pharma isn’t just about tracking pipeline developments—it’s a high-stakes game where missing a key move can cost billions. Yet, time and again, companies fail to anticipate threats because they focus only on obvious competitors, outdated…

After spending two decades in the pharmaceutical industry, I’ve seen companies struggle to stay ahead of competitors, anticipate market shifts, and adapt to unexpected threats. Just like football, the industry is a high-stakes, fast-moving game, where misreading the competition or…